A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension
- PMID: 43164
- PMCID: PMC1429742
A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension
Abstract
1 This study was designed to compare in a double-blind randomized crossover trial, atenolol, labetalol, metoprolol and pindolol. Considerable differences in dose (atenolol 138 +/- 13 mg daily; labetalol 308 +/- 34 mg daily; metoprolol 234 +/- 22 mg daily; and pindolol 24 +/-2 mg daily were required to produce similar antihypertensive effects. 3 The overall incidence of side-effects was similar with atenolol, metoprolol and pindolol but was slightly less with labetalol. Sleep disturbances and abnormal dreaming patterns were most frequent with pindolol. 4 There was a significantly greater fall in pulse rate during atenolol and metoprolol treatment periods.
Similar articles
-
A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.Br J Clin Pharmacol. 1979 Apr;8 Suppl 2:163S-6S. doi: 10.1111/j.1365-2125.1979.tb04774.x. Br J Clin Pharmacol. 1979. PMID: 26635160
-
Labetalol and pindolol in the treatment of hypertension: a comparative study.Ann Clin Res. 1979 Dec;11(6):249-52. Ann Clin Res. 1979. PMID: 398184 Clinical Trial.
-
Comparative tolerability of labetalol versus propranolol, atenolol, pindolol, metoprolol, and nadolol.J Clin Hypertens. 1986 Sep;2(3):285-93. J Clin Hypertens. 1986. PMID: 2878065 Clinical Trial.
-
The role of the new beta-blockers in treating cardiovascular disease.Am J Hypertens. 2005 Dec;18(12 Pt 2):169S-176S. doi: 10.1016/j.amjhyper.2005.09.009. Am J Hypertens. 2005. PMID: 16373195 Review.
-
[Comparison of metroprolol and labetalol. Antihypertensive activity at rest and during exertion and effect on some noninvasive parameters of cardiovascular function].Minerva Cardioangiol. 1981 Dec;29(12):719-28. Minerva Cardioangiol. 1981. PMID: 7038536 Review. Italian. No abstract available.
Cited by
-
Alternatives to beta-blockade in therapy of hypertension with angina pectoris: role of nifedipine or of labetalol.Br J Clin Pharmacol. 1982 Jun;13(1 Suppl):115S-122S. doi: 10.1111/j.1365-2125.1982.tb01899.x. Br J Clin Pharmacol. 1982. PMID: 7093094 Free PMC article.
-
Cold sensitivity in essential hypertension: the effect of beta- and combined alpha- and beta-blockade.Eur J Clin Pharmacol. 1985;29(1):33-6. doi: 10.1007/BF00547365. Eur J Clin Pharmacol. 1985. PMID: 2865156 Clinical Trial.
-
Beta-adrenoceptor blocking drugs: the relevance of intrinsic sympathomimetic activity.Br J Clin Pharmacol. 1982;13(Suppl 2):317S-320S. doi: 10.1111/j.1365-2125.1982.tb01935.x. Br J Clin Pharmacol. 1982. PMID: 6125183 Free PMC article. Review.
-
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.Drugs. 1984;28 Suppl 2:51-68. doi: 10.2165/00003495-198400282-00005. Drugs. 1984. PMID: 6151891 Review.
-
Clinical pharmacokinetics of labetalol.Clin Pharmacokinet. 1984 Mar-Apr;9(2):157-67. doi: 10.2165/00003088-198409020-00003. Clin Pharmacokinet. 1984. PMID: 6370541 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources